Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/12/1996 | US5573925 P53 proteins with altered tetramerization domains |
11/12/1996 | US5573924 Novel receptor cytokine, protein |
11/12/1996 | US5573923 Method for removing N-terminal dipeptides from precursor polypeptides with immobilized dipeptidylaminopeptidase from dictyostelium discoideum |
11/12/1996 | US5573918 Process and reagent for specific determination of pancreatic alpha amylase |
11/12/1996 | US5573916 Vaccines, strengthening secondary response to an antigen |
11/12/1996 | US5573915 Determining the ability of a compound to inhibit the cyclopropanation of mycolic acids in pathogenic mycobacteria |
11/12/1996 | US5573910 Alginate production |
11/12/1996 | US5573908 Adrenergic receptor as a proto-oncogene |
11/12/1996 | US5573905 Encoded combinatorial chemical libraries |
11/12/1996 | US5573767 Lutenizing hormone-releasing hormone |
11/12/1996 | US5573766 Application to plants, active against lepidoptera and coleoptera |
11/12/1996 | US5573764 Use of interleukin-12 to prevent graft versus host disease |
11/12/1996 | US5573763 Family of CSF-l proteins |
11/12/1996 | CA2068438C Essential pure human parathyroid hormone |
11/12/1996 | CA1338721C Backbone polysubstituted chelates for forming a metal chelate-protein conjugate |
11/12/1996 | CA1338720C Derivative of human growth hormone |
11/12/1996 | CA1338708C Neisserial vaccines |
11/12/1996 | CA1338707C Protein h being capable of binding to igg, gene coding for the said protein h and a process for producing the said protein h |
11/12/1996 | CA1338705C Vaccines obtained from antigenic gene products of recombinant genes |
11/07/1996 | WO1996034976A1 Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity |
11/07/1996 | WO1996034974A1 Low oxygen affinity mutant hemoglobin |
11/07/1996 | WO1996034966A2 Engineering protein posttranslational modification in transgenic organisms |
11/07/1996 | WO1996034965A2 Chimeric mcp and daf proteins with cell surface localizing domain |
11/07/1996 | WO1996034960A1 High molecular weight major outer membrane protein of moraxella |
11/07/1996 | WO1996034959A1 Aluminium resistance gene |
11/07/1996 | WO1996034958A1 Vasoactive intestinal peptide |
11/07/1996 | WO1996034957A1 Pancreas-derived serpin |
11/07/1996 | WO1996034956A1 Methods for modulating t cell survival by modulating bcl-xl protein level |
11/07/1996 | WO1996034955A1 Method of treating cartilaginous diseases with genetically modified chondrocytes |
11/07/1996 | WO1996034954A2 Biotin-binding containment systems |
11/07/1996 | WO1996034953A2 Cd16-ii variants |
11/07/1996 | WO1996034952A1 Expression of tap and lmp in tumour cells |
11/07/1996 | WO1996034951A1 Gdu, a novel signalling protein |
11/07/1996 | WO1996034949A1 Plant promoter activated by fungal infection |
11/07/1996 | WO1996034942A1 Novel retrovirus and diagnostic methods |
11/07/1996 | WO1996034940A1 Dna encoding glutamate gated chloride channels |
11/07/1996 | WO1996034893A1 Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits |
11/07/1996 | WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4 |
11/07/1996 | WO1996034890A2 Inhibitors of fibrin cross-linking and/or transglutaminases |
11/07/1996 | WO1996034889A1 Storage stable hemoglobin solutions |
11/07/1996 | WO1996034888A1 Modulation of cholesteryl ester transfer protein (cetp) activity |
11/07/1996 | WO1996034887A2 Antisense peptides |
11/07/1996 | WO1996034886A1 Compositions and methods for detecting and treating acquired immunodeficiency syndrome |
11/07/1996 | WO1996034885A2 Biologically active peptide fragments of ob protein |
11/07/1996 | WO1996034884A2 Synthetic peptides of m. gallisepticum, antibodies thereto, their preparation and use |
11/07/1996 | WO1996034883A1 Acellular pertussis vaccines and methods of preparation thereof |
11/07/1996 | WO1996034882A1 Single chain insulin with high bioactivity |
11/07/1996 | WO1996034881A1 Peptide compositions with growth factor-like activity |
11/07/1996 | WO1996034880A1 Cd6 ligand |
11/07/1996 | WO1996034879A1 Identification of enantiomeric ligands |
11/07/1996 | WO1996034877A1 Human neuropeptide receptor |
11/07/1996 | WO1996034873A1 Recombinant endotoxin-neutralizing proteins |
11/07/1996 | WO1996034627A1 Murine and human box-dependent myc-interacting protein (bin1) and uses therefor |
11/07/1996 | WO1996034625A1 Recombinant vesiculoviruses and their uses |
11/07/1996 | WO1996034624A1 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides |
11/07/1996 | WO1996034623A1 Acellular pertussis vaccines and methods of preparation thereof |
11/07/1996 | WO1996034622A1 Modified myelin protein molecules |
11/07/1996 | WO1996034619A1 Methods of preventing neuron degeneration and promoting neuron regeneration |
11/07/1996 | WO1996034618A1 Tissue adhesive using synthetic cross-linking |
11/07/1996 | WO1996030520A3 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein |
11/07/1996 | WO1996029409A3 Rage tumor rejection antigens |
11/07/1996 | WO1996025507A3 Methods of preparation and use of recombinant adenoviral vectors |
11/07/1996 | WO1996022379A3 Direct gene transfer into the ruminant mammary gland |
11/07/1996 | WO1996015241A3 A polynucleotide tuberculosis vaccine |
11/07/1996 | DE19516040A1 Increasing immune response to tumour cells by increasing expression of TAP or LMP proteins |
11/07/1996 | CA2433502A1 Acellular pertussis vaccines and methods of preparation thereof |
11/07/1996 | CA2231854A1 Novel retrovirus and diagnostic methods |
11/07/1996 | CA2223272A1 Single chain insulin with high bioactivity |
11/07/1996 | CA2220333A1 Plant promoter activated by fungal infection |
11/07/1996 | CA2220268A1 Inhibitors of fibrin cross-linking and/or transglutaminases |
11/07/1996 | CA2220123A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4 |
11/07/1996 | CA2220109A1 Engineering protein posttranslational modification in transgenic organisms |
11/07/1996 | CA2220098A1 Cd6 ligand |
11/07/1996 | CA2220036A1 Human neuropeptide receptor |
11/07/1996 | CA2220016A1 Gdu, a novel signalling protein |
11/07/1996 | CA2219936A1 Vasoactive intestinal peptide |
11/07/1996 | CA2219889A1 High molecular weight major outer membrane protein of moraxella |
11/07/1996 | CA2219775A1 Murine and human box-dependent myc-interacting protein (bin1) and uses therefor |
11/07/1996 | CA2219020A1 Tissue adhesive using synthetic cross-linking |
11/07/1996 | CA2218858A1 Modified myelin protein molecules |
11/07/1996 | CA2218083A1 Identification of enantiomeric ligands |
11/07/1996 | CA2218034A1 Pancreas-derived serpin |
11/07/1996 | CA2216382A1 Storage stable hemoglobin solutions |
11/06/1996 | EP0741189A1 Process for producing human growth hormone |
11/06/1996 | EP0741188A2 Single chain insulin with high bioactivity |
11/06/1996 | EP0741187A2 Recombinant obese (Ob) proteins |
11/06/1996 | EP0741143A2 Fibroblast growth factor fragments |
11/06/1996 | EP0741142A1 Peptide and antithrombotic agent |
11/06/1996 | EP0741141A2 Method of purifying ologonucleotide from biological samples |
11/06/1996 | EP0740939A1 Compositions for treatment and prophylaxis of atherosclerosis |
11/06/1996 | EP0740792A1 Peptomers with enhanced immunogenicity |
11/06/1996 | EP0740791A1 Systematic modular production of aminimide- and oxazolone-based molecules having selected properties |
11/06/1996 | EP0740708A1 Design of drugs involving receptor-ligand-dna interactions |
11/06/1996 | EP0740707A1 Secretion of proteins from the outer membrane of gram-negative bacteria by gram-positive host organisms |
11/06/1996 | EP0740704A1 Immunization by inoculation of dna transcription unit |
11/06/1996 | EP0740703A1 Diagnosis and treatment of infections due to streptococci and enterococci |
11/06/1996 | EP0740702A1 Novel human amyloid protein precursor homologue and kunitz-type inhibitors |
11/06/1996 | EP0740701A1 Mammalian monocyte chemoattractant protein receptors |
11/06/1996 | EP0740700A1 Natural resistance associated macrophage protein and uses thereof |
11/06/1996 | EP0740699A1 Cell lines, maturation factors and use of said cell lines and factors |